The Top 7 CDMO Leadership Trends for 2026 – And Why Up to 50-65% of Exec Hires Still Fail in Year One
The global CDMO market is racing toward ~$211-273B by 2026, powered by biologics, ADCs, cell & gene therapies, and relentless sponsor demand for speed and quality. Yet here’s the uncomfortable paradox: Up to 50–65% of executive hires in complex, regulated sectors fail within their first year. That failure shows up fast – missed capacity […]
CDMOs in 2026: The New Rules of Winning
The CDMO landscape is evolving quickly, and 2026 will reward those who can balance scale, specialization, and regulatory muscle. Here’s a look at the trends shaping the next 12-18 months. 1. Growth continues – but shifts in shape The market is still expanding, but unevenly. API and small-molecule outsourcing remain solid, while biologics and […]